Stay updated on Avelumab-cetuximab-radiotx vs SOCs in LA SCCHN Clinical Trial

Sign up to get notified when there's something new on the Avelumab-cetuximab-radiotx vs SOCs in LA SCCHN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab-cetuximab-radiotx vs SOCs in LA SCCHN Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer’s site revision label changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T02:47:33.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the REACH Phase 3 study record for avelumab, cetuximab, and radiotherapy versus standards of care for locally advanced head and neck cancer. It includes study design, participant criteria, locations, recruitment status, and measured outcomes.
    Difference
    54%
    Check dated 2026-11-11T01:55:13.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-04T00:13:04.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” was added, and the site revision changed from v3.7.1 to v3.7.2. The study page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:18:34.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:23:19.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study details with an access restriction; as a result, the record cannot be viewed.
    Difference
    19%
    Check dated 2026-09-23T00:15:23.000Z thumbnail image

Stay in the know with updates to Avelumab-cetuximab-radiotx vs SOCs in LA SCCHN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab-cetuximab-radiotx vs SOCs in LA SCCHN Clinical Trial page.